Orion Biotechnology Canada Ltd. is a drug discovery and development company headquartered in Ottawa, Canada. Founded in 2017, the firm focuses on researching and developing innovative therapeutics targeting complex diseases. Its scientific pipeline utilizes proprietary drug design platforms to create novel targeted treatments.
Subscribe to see Orion Biotechnology Canada Ltd.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Orion Biotechnology Canada Ltd. is a company headquartered in Ottawa, Canada. Its most recent funding round raised $6.8M in July 2024. Xcout tracks 11 named people at Orion Biotechnology Canada Ltd., including Praveen Tyle (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
5 more named people on record for Orion Biotechnology Canada Ltd., with roles, board committees and tenure — see the full roster →
The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $6.8M | — | |
| SEC Form D filing | $9.9M | — | |
| Series A | $11.5M | 1 named | |
| SEC Form D filing | $605,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Orion Biotechnology Canada Ltd.'s closest competitors — see the full list of competitors and alternatives →
Orionis Biosciences is a biotechnology research company with its US headquarters located in Waltham, Massachusetts, specializing in innovative life sciences and drug discovery services.
Orion Therapeutics, Inc. is a therapeutic and RNA therapeutics company enabled by a novel delivery platform. The company is headquartered in Knoxville, Tennessee.
Radiant Biotherapeutics, Inc. is a biotechnology company focused on developing drug pipelines and therapeutic platforms primarily addressing neoplasms and other disease domains. The company operates in Canada with a growing team of professionals engaged in advanced biotherapeutic research.
Allorion Therapeutics is a US-based organization headquartered in Natick, Massachusetts, with additional operations in China, specializing in the discovery and creation of small molecule drugs using a science- and data-driven R&D strategy.
Octant Bio is a biotechnology company that combines next-generation biology, chemistry, and computation to discover and develop precision small molecule therapeutics. The company targets complex cellular mechanisms to address genetic diseases, such as protein misfolding and mistrafficking across various therapeutic areas including genetic disorders, oncology, metabolism, and immunology.
Serán Bioscience is a drug development company headquartered in Bend, Oregon, that combines state-of-the-art technology with scientific expertise to advance pharmaceutical formulations.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Orion Biotechnology Canada Ltd.? Suggest a correction · Work at Orion Biotechnology Canada Ltd.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.